Optic nerve glioma medical therapy

Revision as of 01:58, 6 October 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Optic nerve glioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Optic nerve glioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Optic nerve glioma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Optic nerve glioma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Optic nerve glioma medical therapy

CDC on Optic nerve glioma medical therapy

Optic nerve glioma medical therapy in the news

Blogs on Optic nerve glioma medical therapy

Directions to Hospitals Treating Optic nerve glioma

Risk calculators and risk factors for Optic nerve glioma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The mainstay of therapy for optic nerve glioma is chemotherapy, radiation therapy, and hormone replacement therapy.

Medical Therapy

Treatment of optic nerve glioma depend on clinical context, as well as on location of the tumor at presentation. If it is isolated to one optic nerve, and does not extend to the chiasm, then resection is curative (albeit with loss of vision in that eye). If the tumour extends to the chiasm or more posteriorly then curative resection is not possible, with resection reserved for treatment of mass effects (proptosis, intracranial mass effect). Treatment of optic nerve glioma varies with general health of the person and the size of the tumor. The goals of the treatment is to improve vision, relieve symptoms, and cure the disorder.[1] The most common treatments for optic nerve glioma are:

Observation

Observation as a treatment modality is used, particularly in patients with good vision on the involved side. At regular intervals, follow-up examinations, and appropriate radiographic studies, preferably MRI, must be performed. Many patients if regularly followed up maintain good vision and never require a surgery.

Chemotherapy

  • Chemotherapy is used in children to delay radiation therapy, and to reduce the severity of radiation therapy induced side-effects.
  • Chemotherapy has the ability to cause tumor regression and stabilize the vision.
  • Chemotherapy may be useful when the tumor extends into the hypothalamus, as it has an ability to shrink hypothalamic tumors.
  • It is useful in diencephalic syndrome as it allows for weight gain.
  • Approximately sixty percentage of children treated with chemotherapy for gliomas of the hypothalamus and optic pathways had a relapse.[2]
  • Chemotherapy may carry long-term risks of blood-borne cancers.

Combination chemotherapy using vincristine, actinomycin D, bevacizumab, etoposide, and other agents has also been reported to be effective in patients with progressive hypothalamic/chiasmal gliomas. Chemotherapy alone very rarely cures low-grade gliomas. Mostly, chemotherapy can stop the progression of optic nerve gliomas. But if the tumor is resistant to chemotherapy, radiation is an option.

Radiation

  • Radiation therapy is used if the tumor is resistant to chemotherapy
  • Radiation therapy is not generally used in children less than five years of age and usually avoided in children between five and ten years of age. Radiation therapy is delayed in young children to reduce the risk of significant side- effects such as developmental and neurocognitive delay.
  • Radiation therapy is considered if the tumor is unresectable (optic tract or chiasmal lesions), and if neurological symptoms progress.
  • Radiation therapy can be done before surgery to shrink the tumor before removing it or after surgery to kill the remaining cancer cells. If chiasmal and optic tract involvement is extensive and if there is growth of the tumor within the chiasm, postoperative radiation of the chiasm and optic tract may be considered.
  • Where the tumor is larger and surgery is not possible, radiation therapy may be recommended. In slow growing tumor, radiation therapy may be delayed.
  • Corticosteroids may be prescribed if symptoms return or to reduce swelling and inflammation caused during radiation therapy.

Complications of radiation therapy

Hormone replacement therapy

Lifelong hormone replacement therapy is used if the endocrine systems is affected.

Alternative medicine

Alternative medicines to control pain and treatment side effects may be used, alternative medicines include:

  • Acupuncture/acupressure
  • Therapeutic touch
  • Herbal supplements
  • Dietary recommendations
  • Message

References

  1. Optic nerve glioma. Radiopedia(2015) http://radiopaedia.org/articles/optic-nerve-glioma Accessed on October 2 2015
  2. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH; et al. (1995). "Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up". Cancer. 75 (4): 1051–9. PMID 7842408.
  3. Kovalic JJ, Grigsby PW, Shepard MJ, Fineberg BB, Thomas PR (1990). "Radiation therapy for gliomas of the optic nerve and chiasm". Int J Radiat Oncol Biol Phys. 18 (4): 927–32. PMID 2323979.
  4. Kingsley DP, Kendall BE (1981). "CT of the adverse effects of therapeutic radiation of the central nervous system". AJNR Am J Neuroradiol. 2 (5): 453–60. PMID 6792884.
  5. 5.0 5.1 Bataini JP, Delanian S, Ponvert D (1991). "Chiasmal gliomas: results of irradiation management in 57 patients and review of literature". Int J Radiat Oncol Biol Phys. 21 (3): 615–23. PMID 1907959.
  6. Epstein MA, Packer RJ, Rorke LB, Zimmerman RA, Goldwein JW, Sutton LN; et al. (1992). "Vascular malformation with radiation vasculopathy after treatment of chiasmatic/hypothalamic glioma". Cancer. 70 (4): 887–93. PMID 1643622.
  7. Kestle JR, Hoffman HJ, Mock AR (1993). "Moyamoya phenomenon after radiation for optic glioma". J Neurosurg. 79 (1): 32–5. doi:10.3171/jns.1993.79.1.0032. PMID 8315466.

Template:WH Template:WS